Login

2025 International Conference on Biofabrication

14–17 Sept 2025
Palace of Culture and Science
Europe/Warsaw timezone

Contact

Session

S15 Bioprinting approaches in the EU projects

16 Sept 2025, 15:30
Goethe

Goethe

Conveners

S15 Bioprinting approaches in the EU projects

  • Ayça Bal Öztürk (Istinye University and ADBioink, Turkey)
  • Giovanni Vozzi (University of Pisa, Italy)

Presentation materials

There are no materials yet.

  1. 591. Clusters as tools for enhanced collaboration and increased impact of Horizon Europe projects
    Giulia Lionetti
    16/09/2025, 15:30
    remote-TEAMS
  2. 544. ILLUMINATING in situ bioprinting for joint regeneration
    Marcy Zenobi-Wong (ETH Zurich)
    16/09/2025, 15:40
    invited lecture

    The LUMINATE consortium develops a personalized, one-stage regenerative approach to target large osteochondral lesions, thus preventing post-traumatic osteoarthritis and the associated patient burden. The LUMINATE consortium aims to develop an in situ bioprinting unit, called EndoFLight, which combines three pinting methods (filamented light, micro-extrusion, jetting) to print cartilage and...

    Go to contribution page
  3. 22. The m2M project: A bioprinting platform for the rapid, reliable, controlled and quantifiable patterning of cellular aggregates and microtissues into macroscale regenerative grafts with programmable architectures.
    Daniel Kelly (Trinity College Dublin)
    16/09/2025, 16:00
    invited lecture

    A fundamental limitation with current approaches aiming to bioprint tissues and organs is an inability to generate constructs with truly biomimetic composition and structure, resulting in the development of engineered tissues that cannot execute their specific function in vivo. This is perhaps unsurprising, as many tissues and organs continue to mature postnatally, often taking many years to...

    Go to contribution page
  4. 357. Innovative in situ 4D bioprinting for regeneration of colorectal mucosa and submucosa
    Jürgen Groll (Univeristy of Würzburg)
    16/09/2025, 16:10
    podium presentation

    Colorectal diseases are a cohort of pathologies that affect the mucosa and submucosa layers of the anus, rectum, and colon of more than 2 million individuals in the European Union [1]. Among them, familiar adenomatous polyposis (FAP) and ulcerative colitis (UC) seriously compromise the patients’ quality of life. These pathologies could benefit from the removal of the intestinal mucosa and...

    Go to contribution page
  5. 315. 3D Bioprinting with Self-Healing, Photocurable Supramolecular Hydrogels without Photo-Initiators
    Cristian P. Pennisi (Aalborg University)
    16/09/2025, 16:18
    podium presentation

    Introduction
    Hydrogels are three-dimensional networks of polymers that can absorb and store large amounts of water. Conventional hydrogels are based on static covalent crosslinks, which limits their adaptability to varying mechanical loads and environmental conditions. In supramolecular hydrogels the chains in the network are connected by reversible physical bonds that confer viscoelastic...

    Go to contribution page
  6. 313. LUMINATE: lighting the way towards in situ osteochondral regeneration through microextrusion and filamented light bioprinting
    Giovanni Vozzi (University of Pisa)
    16/09/2025, 16:26
    podium presentation

    Traumatic injuries to the osteochondral tissues of diarthrodial joints like the knee result in pain, functional impairment, and increased risk of developing post-traumatic osteoarthritis (PTOA) and its comorbidities. Strikingly, up to 50% of patients suffering from severe trauma to the knee joint develop PTOA within 10 years from the injury. Current treatments, based on allografts, cell-free...

    Go to contribution page
  7. 220. Automated generation of dense, functional, and perfusable bioprinted liver constructs for transplantation
    Bart Spee (Utrecht University)
    16/09/2025, 16:34
    podium presentation

    Organ transplantation remains the only curative treatment for patients with end-stage liver disease, yet the chronic shortage of donor organs leaves thousands of patients without timely access to life-saving therapies. Approximately 25% of patients on the liver transplant waiting list either die or deteriorate beyond eligibility. To address this critical gap, the NEOLIVER project aims to...

    Go to contribution page
  8. 432. Traceable and verifiable design inputs for AI-powered medical devices: Insights from the LUMINATE projects
    Amedeo Franco Bonatti (University of Pisa)
    16/09/2025, 16:42
    podium presentation

    Background
    Biofabrication technologies are advancing rapidly, offering novel therapeutic strategies for regenerating complex tissue defects. The LUMINATE project, co-funded under the Horizon Europe programme, focuses on the development of an AI-powered bioprinter for intraoperative repair of osteochondral tissue. The device combines high-precision material deposition and AI-powered process...

    Go to contribution page
  9. 330. Advanced 4D biomaterials for mucosa and submucosa treatment in patients affected by colorectal diseases
    Irene Chiesa (University of Pisa)
    16/09/2025, 16:50
    podium presentation

    Colorectal diseases refer to a range of conditions that affect the mucosal and submucosal layers of the anus, rectum, and colon, impacting over 2 million individuals across the European Union [1]. Among these, familial adenomatous polyposis (FAP) and ulcerative colitis (UC) significantly reduce the quality of life of affected patients. While these conditions might benefit from removing the...

    Go to contribution page
Building timetable...